Q4 2023 13F Holders as of 31 Dec 2023
-
Type / Class
-
Equity / American Depository Shares
-
Shares outstanding
-
1,786,081
-
Total 13F shares
-
4,883,338
-
Share change
-
+4,641,995
-
Total reported value
-
$2,151,708
-
Price per share
-
$0.44
-
Number of holders
-
17
-
Value change
-
+$2,045,684
-
Number of buys
-
11
-
Number of sells
-
3
Institutional Holders of KAZIA THERAPEUTICS LTD - American Depository Shares (KZIA) as of Q4 2023
As of 31 Dec 2023,
KAZIA THERAPEUTICS LTD - American Depository Shares (KZIA) was held by
17 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
4,883,338 shares.
The largest 10 holders included
ARMISTICE CAPITAL, LLC, PLATINUM INVESTMENT MANAGEMENT LTD, MORGAN STANLEY, BANK OF MONTREAL /CAN/, HSBC HOLDINGS PLC, TWO SIGMA SECURITIES, LLC, XTX Topco Ltd, ACADIAN ASSET MANAGEMENT LLC, CITADEL ADVISORS LLC, and BNP PARIBAS FINANCIAL MARKETS.
This page lists
17
institutional shareholders reporting positions in this security
for the Q4 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.